When is patient transfer considered in the treatment of MDMA toxicity?

Updated: May 30, 2020
  • Author: In-Hei Hahn, MD, FACEP, FACMT; Chief Editor: Jeter (Jay) Pritchard Taylor, III, MD  more...
  • Print

Patients may require transfer to a psychiatric facility for evaluation and treatment if they exhibit dangerous behavior or psychosis refractory to general supportive measures. However, patients must be stable, without hemodynamic instability and with no evidence of cardiac, cerebral, renal, hepatic, or pulmonary complications.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!